For citations:
Fel’dblyum I.V., Subbotina K.A., Uvarova E.V., Pekareva N.A., Alekseeva E.I., Polibin R.V., Yudina V.S., Galustyan A.N., Romanenko V.V., Golodnova S.O. Safety and Immunogenicity of First Russian Quadrivalent (Recombinant, Adsorbed) Human Papillomavirus (Types 6, 11, 16, 18) Vaccine in Children Aged 9–17 Years: Multicenter, Randomized, Double-Blind, Phase III Clinical Trial. Current Pediatrics. (In Russ.) https://doi.org/10.15690/vsp.v25i4.3091
JATS XML
Email this article 
